A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Anne-Cecile EzannoBrice MalgrasOlivier AounAmaury DelargeAlice DoreilleMarc PocardPublished in: Pleura and peritoneum (2022)
The OIIS is a rare. Physicians had to be aware of that clinical situation because it could be reversible, even in case of peritoneal advanced disease, and ICU treatment is justified.